ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE. Available dosage form: capsule.
Drug Details
- Generic Name
- ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
- Brand Names
- ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
- Application Number
- ANDA210318
- Sponsor
- Glenmark Pharmaceuticals Inc., USA
- NDC Codes
- 1
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- ASPIRIN, DIPYRIDAMOLE
Indications and Usage
1 INDICATIONS AND USAGE Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. • Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )